Woodside Energy Group Ltd
WDS
National Australia Bank Ltd
NAB
BHP Group Ltd
BHP
4
Origin Energy Ltd
ORG
5
Fortescue Ltd
FMG
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.